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Susac’ssyndromeisanuncommonneurologicdisorderofunknowncause.Ithasbeendescribedasaclinicaltriadofencephalopathy,
hearing loss, and branch retinal artery occlusions. Clinically the diagnosis is difficult when the patient presents only a portion of
a triad. We present a case with vision loss and sensorineural deafness and who had been diagnosed with MS for 20 years. Susac’s
syndrome is presumed to be an autoimmune endotheliopathy. Neurologic symptoms and signs are diffuse and multifocal, acute
or subacute in onset, and progress during the active phase of the disease. In some patients the onset was stroke like and in others
that of subacute dementia. Headache, often with migrainous features, was a prominent feature initially in more than one half of the
patients.Ahighindexofsuspicionleadingtocorrectdiagnosisandearlyappropriatetherapymayreducethepermanentsequelseen
withthisdisease.Misdiagnosisiscommon.Inpatientsinwhomdiagnosisandtreatmentaredelayedpermanentmorbidityishigher
in terms of visual loss, hearing loss, and neurologic debility. In patients in whom rapid diagnosis has led to early administration of
immunosuppressive therapy, recovery can be almost complete.
1. Introduction
Susac’s syndrome (SS) is an uncommon neurologic disorder
of unknown cause. It has been described as a clinical triad of
encephalopathy,hearingloss,andbranchretinalarteryocclu-
sions. Clinically the diagnosis is difficult when the patient
presents only a portion of a triad [1].
Wepresentacasewithvisionlossandsensorineuraldeaf-
n e s sa n dw h oh a db e e nd i a g n o s e dw i t hM Sf o r2 0y e a r s .
2. Case Report
A 41-year-old male patient was admitted to our outpatient
clinic with a 20-year diagnosis of MS. On ophthalmic exami-
nationthevisualacuityinthelefteyewas20/100and20/20in
the right eye. No other neurological deficit or abnormality
was identified in the neurological examination. In his past
m e d i c a lh i s t o r y ,h eh a dl o s so fv i s i o ni nt h el e fte y e2 0y e a r s
earlier,whichdidnotimproveatthattime.Hewasdiagnosed
withMSandhadreceived,oncepermonth,IV1000mgmeth-
ylprednisolone treatment for a couple of years. Seven years
ago,hehadsuddendeafnessintheleftear.Anaudiogramper-
formed at that time showed total sensory neural deafness in
t h el e fta n d2 0 %l o s so fh e a r i n gi nt h er i g h te a r .B r a i nM R I
findings were interpreted as consistent with a demyelinating
disease.Oneyearago,hehadsuddenlossofvisioninhisright
eye. A fluorescein angiogram performed at that time showed
branch retinal artery occlusion in the right eye (Figure 1).
His pattern-shift visual evoked potential (PVEP) record-
ings at that time showed a prominent positive wave (P100)
with a peak latency of 114ms (n: 90–120ms) in the right eye,
w h i l en ow a v ef o r mc o u l db eo b t a i n e df r o mt h el e fte y e .H e
was treated with hyperbaric oxygen and 100mg aspirin and
he stated that his vision had returned to nearly normal within
20 days.
Fromtheevidenceinhispastmedicalhistory,wereevalu-
ated the patient and reached a diagnosis of Susac’s syndrome.
T2-weighted brain magnetic resonance imaging (MRI) dem-
onstrated multiple small foci of increased signal intensities
(Figure 2).
An electroencephalography (EEG) showed mild diffuse
slowing of the cerebral bioelectrical activity. Background
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Figure 1: (a) Fundus photograph of the right eye with superior hemiretinal edema due to superotemporal branch retinal artery occlusion.
(b) Fluorescein angiogram of the right eye revealed the presence of delayed filling of the superotemporal branch retinal artery.
(a) (b)
Figure 2: (a) T2-weighted sagittal and (b) axial flair images revealed the presence of small hyperintense pericallosal lesions and
supraventricular white matter lesions.
activity was characterized by low voltage slow alpha rhythm
(7-8Hz) with superimposed 4–6Hz rare theta activity espe-
cially in frontotemporal regions (Figure 3).
I nb r a i ns t e ma u d i t o r ye v o k e dp o t e n t i a l( B A E P )t e s t i n g ,
nowaveformwasobtainedfromtheleftear,whileI,II,andIV
waveswithnormalpeakandinterpeaklatencieswerepresent
o nt h er i g h t .C o n t r o lV E P1y e a ra ft e rt h ee v e n to nt h er i g h t
eye showed that the latency of P100 in the right eye had
declinedfrom114msto102ms.CranialMRangiographyand
transthoracic and transesophageal echocardiography were
normal.
ANA was weakly positive with high RF. Hematological
and biochemical evaluations, including ferritin, vitamin B12,
andhomocysteine,werenormal.Plateletcount,prothrombin
time, partial thromboplastin time, fibrinogen, D-dimer, and
sedimentation rate were within normal limits. ACA, AFA,
LA,anddsDNAwerenegative.Antiphospholipidantibodies,
C-reactiveprotein,totalIgA,IgM,IgE,C3,C4,andahepatitis
screen were all normal.
He had not received any treatment for Susac’s syndrome
overthelast20yearsandhadhadatotalofthreeattacks(two
from the eyes, one from the ears). We questioned him again
regarding neuropsychiatric symptoms. He had never had any
neuropsychiatric symptom although his EEG revealed the
presence of bilateral frontotemporal slowing. A number of
patientswhohadwhatappearstobeapartialformofthesyn-
drome, for example, cochlear and retinal involvement with-
out cerebral symptoms [2–5]asinourpatientorcerebraland
retinal involvement without hearing loss [6] or retinal in-
volvement alone [2], have been reported. It has been stated
t h a tM R Ifi n d i n g sm a yb ea b n o r m a le v e ni nt h ea b s e n c eo f
symptoms specifically referable to the brain in patients with
these partial forms [5, 7].Case Reports in Neurological Medicine 3
Figure 3: Mild diffuse slowing of the cerebral bioelectrical activity. Background activity was characterized by low voltage slow alpha rhythm
(7-8Hz) with superimposed 4–6Hz rare theta activity especially in frontotemporal regions.
3. Discussion
Susac’ssyndromewasfirstdescribedin1979[1].Thediseaseis
also known as (a)-RED-M which stands for retinopathy, en-
cephalopathy, and deafness associated microangiopathy, (b)
SICRET (small infarct of cochlear, retinal, and encephalic
tissues), and (c) retinocochleocerebral vasculopathy [8].
Although SS occurs in young women between the ages of
2 0a n d4 0 ,i tm a ya ffl i c tm e n .Th ea g er a n g ei nb o t hs e x e s
is from 16 to 58 years, and the male to female ratio is 3:1 [9].
Affectedpatientshavemultiplebranchretinalocclusionsthat
typically are bilateral, progressive hearing loss, and various
neurologic presentations including but not limited to psy-
chiatric changes and encephalopathy [10]. The branch retinal
artery occlusion may be quite extensive and spectacular or
m a yb ev e r ys u b t l e[ 11]. Arteriolar occlusions usually are
caused by emboli that typically are fleeting in nature [10]. If
the infarctions are extensive and involve the posterior pole,
thepatientwillcomplainofimpairedvision.Iftheocclusions
occur in the more peripheral portion of the retina or if the
patient is encephalopathic, he may not describe visual symp-
toms. The branch retinal artery occlusions are invariably
bilateralandmaybethepresentingsymptomsoftheillnessor
occur later in the clinical course [11].
Hearing loss can be a dramatic and severely disabilating
feature of SS. It often occurs overnight and may affect both
ears. A loss of low or middle frequencies is typical, but loss of
high frequencies can also occur [12]. The predominance of
low and medium tone loss is suggestive of cochlear apical
damage caused by occlusions of the cochlear end arterioles.
Loss of high-frequency tone is a marker of more significant
cochlear damage [10]. The hearing loss is often accompanied
by vertigo and tinnitus [12]. The cranial nerves are not
involved in Susac’s syndrome. The hearing loss is due to
cochlear involvement and vertigo if present is due to semi-
circular canal involvement [13].
Neurologic symptoms and signs are diffuse and multifo-
cal,acu teo rsubacu teino nset,a ndp r ogr essd uringtheactive
phaseofthedisease.Insomepatientstheonsetwasstrokelike
andinothersthatofsubacutedementia.Headache,oftenwith
migrainousfeatures,wasaprominentfeatureinitiallyinmore
t h a no n eh a l fo ft h ep a t i e n t s .M o s tp a t i e n t sh a v ea b n o r m a l i -
ties in cognition, memory, behavior and affect including pse-
udobulbar behavior and abulia sometimes with bizarre neu-
ropsychiatric manifestations [7]. The encephalopathy may
progress to a stage where the patient is totally unable to com-
municate. Seizures and myoclonus may occur [11].
S u s a c ’ ss y n d r o m ei sp r e s u m e dt ob ea na u t o i m m u n ee n -
dotheliopathy.Inbiopsiesofthebrain,microinfarctswithloss
of neurons, axons, and myelin in the white and grey matter
could be detected. The microinfarcts are caused by microan-
giopathic process with arteriole wall proliferation, lympho-
cyte infiltration, destruction of the capillary network, and
basal lamina thickening [12]. Diagnosis and management
often require a multidisciplinary effort involving a neurol-
ogist, neuroopthalmologist, otolaryngologist, neuroradiol-
ogist, and rheumatologist [14]. Brain magnetic resonance
(MR) imaging plays an important role in evaluation of
patients suspected of having SS [8]. On MRI, the typical
lesions are small multifocal lesions of 3–7mm. The most
importantdiagnosticsignandverytypicalforSSisthesnow-
ball-like lesions in the center of the corpus callosum. At the
onset of the disease, before treatment contrast enhancement
around small vessels representing a perivascular leakage and
leptomeningeal contrast enhancement can be seen. Other
typical MRI findings are a series of small central holes that
gives the corpus callosum a riddled aspect. The snowballs
resultinresidualholes,especiallyinthespleniumofthec.cal-
losum. The linear defect of the corpus callosum reflects mic-
roinfarct of obliquely radiating axons, the so called “spokes”
or wedged shaped lesions extending from the corpus callo-
sum, the so called “icicles.” The most important differential4 Case Reports in Neurological Medicine
diagnosesaremultiplesclerosis(MS)andacutedisseminated
encephalomyelitis (ADEM). In MS and ADEM, the lesions
are on the undersurface and at the septal interface of the cor-
p u sc a l l o s u m .I nS S ,t h el e s i o n sa r el y i n go nt h ec e n t e ro ft h e
corpuscallosumandaresparingtheperipheryofit.InADEM
andMSleptomeningealenhancementisuncommon.MShas
typicallyovoidlesionswhereasthelesionsinSSareroundand
resemble snowballs. MS is a disease predominantly involving
the white matter whereas deep gray matter involvement is a
common finding in SS [12]. Spinal fluid examination has in-
variably shown an elevated protein in the range of 100 to
790mg/dL and minimal pleocytosis (5–15 lymphocytes)
occursoccasionally[11].EEGshowsdiffuseslowing[15]while
cerebral arteriography findings are almost normal, because
thein v o l v edp r eca p illa rya rterio les(<100𝜇m)arebeyondthe
resolution of arteriography. Fluorescein angiography how-
everisextremelyusefulandwilloftenshowthebranchretinal
a r t e r yo c c l u s i o na sw e l la st h ep a t h o g n o m o n i cm u l t i f o c a l
fluorescence of the branch arterioles [13].
The classical triad is pathognomonic for SS, but the three
elements are not always present at the same time [1]. One or
t w oo ft h ec l a s s i c a lt r i a dm a yb ea b s e n ts y m p t o m a t i c a l l y
and/or be difficult to detect clinically, especially at presenta-
tion but often beyond [16].Patientsmaypresentwithisolated
encephalopathy, unexplained visual disturbance, or hearing
loss and go undiagnosed until a full triad is assumed [14].
B a s e do nt h eh y p o t h e s i so fi tb e i n ga na u t o i m m u n ed i s e a s e ,
treatment has to be immunosuppressive. Considering the
oftensevereresidualdeficitsofbrain,eye,andearfunctionsin
thesemainlyyoungpatients,treatmenthastobesignificantly
aggressivetopreventfurtherdamageandrelapses[12].Treat-
mentwithIVmethylprednisolonefollowedbyoralsteroidsis
recommended [13]. Intravenous immunoglobulin (IV IG)
can be useful in severe cases. In severe and disabilating cases,
further immunosuppressants like cyclophosphamide, myco-
phenolate mofetil, or rituximab should be added to gluco-
corticoids and IV IG [12]. The clinical course of SS is usually
self-limited,fluctuating,andmonophasic.Itlastsfromtwoto
f o u ry e a r sb u tm a yb ea ss h o r ta ss i xm o n t h so ra sl o n ga s
five years in duration [13], but the exact duration in the indi-
vidual patient is unpredictable. Relapses after decades, have
been described. This requires monitoring for a lifelong time
[12]. Although some patients recover with little or no resid-
ual disease, others are profoundly impaired with cognitive
deficits, gait disturbance, and hearing loss. Usually vision is
not seriously impaired [13].
A high index of suspicion, leading to correct diagnosis
and early appropriate therapy may reduce the permanent
sequel seen with this disease. Misdiagnosis is common. In
patientsinwhomdiagnosisandtreatmentaredelayedperma-
nent morbidity is higher in terms of visual loss, hearing loss,
and neurologic debility. In patients in whom rapid diagnosis
has led to early administration of immunosuppressive ther-
a p y ,r e c o v e ryc a nb ea l m o s tc o m p l e t e[ 10].
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